Embattled Alzheimer's Researcher Is Charged With FraudOne scientist charged with fraud for falsifying data to secure $16 million in research grants for Alzheimer's drug studies.
Officials Cast Doubt on a Dementia Drug, but Human Trials ContinueThe regulatory approval path for simufilam is fraught with controversy and allegations of research misconduct.
Trial of Controversial Alzheimer's Drug Halted After Disappointing ResultsCassava Sciences halted the advanced trial for simufilam as it failed to reduce cognitive decline in Alzheimer's patients, disappointing many.
Embattled Alzheimer's Researcher Is Charged With FraudOne scientist charged with fraud for falsifying data to secure $16 million in research grants for Alzheimer's drug studies.
Officials Cast Doubt on a Dementia Drug, but Human Trials ContinueThe regulatory approval path for simufilam is fraught with controversy and allegations of research misconduct.
Trial of Controversial Alzheimer's Drug Halted After Disappointing ResultsCassava Sciences halted the advanced trial for simufilam as it failed to reduce cognitive decline in Alzheimer's patients, disappointing many.